stock split
HTG Molecular Completes 1-For-15 Reverse Stock Split
The company stock will now trade on a split-adjusted basis on the Nasdaq after reducing its number of shares from 200 million to 26.7 million.
Biocept Completes Reverse Stock Split, Adds New Managed Care Contract for Liquid Biopsy Tests
The company's stock will now trade on a split-adjusted basis on the Nasdaq after authorization for the split was approved by stockholders.
Interpace Biosciences to Sell $20M in Preferred Stock, Plans Reverse Stock Split
The company recently changed its name from Interpace Diagnostics as it expands its focus to include drug discovery and development services.
OpGen Plans Reverse Stock Split
The disclosure comes less than a week after the company said that it was out of compliance with the Nasdaq's minimum shareholder equity requirement.
Precipio to Effect 1-for-15 Reverse Stock Split
The cancer diagnostics developer said it was undertaking the reverse stock split in order to meet the Nasdaq's $1 minimum bid price requirement.
Jan 17, 2018
OpGen to Execute 1-for-25 Reverse Stock Split
Jun 2, 2017
Pressure Biosciences Plans Reverse Stock Split
Mar 16, 2017
Rosetta Genomics Announces Reverse Stock Split
Dec 28, 2016
Interpace Effecting a 1-for-10 Reverse Stock Split
Dec 23, 2016
Great Basin to Effect 1-for-300 Reverse Stock Split
Nov 28, 2016
WaferGen Enacts Reverse Stock Split
Oct 11, 2016
Roka Bioscience Plans 1-for-10 Reverse Stock Split
Sep 15, 2016
Great Basin Scientific Plans Reverse Stock Split
Jan 27, 2016
CombiMatrix Initiates 1-for-15 Reverse Stock Split
Oct 8, 2015